臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52508140 線上人數 : 803 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pu y s"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 281-290 / 627 (共63頁)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-03-04T02:35:59Z	Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells	Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; YU-CHIEH TSAI; Pu Y.-S.; Chiang C.-K.; Liu S.-H.
臺大學術典藏	2021-03-04T02:35:58Z	MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies	Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; YU-CHIEH TSAI; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H.
臺大學術典藏	2021-03-04T02:35:57Z	MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma	Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; YU-CHIEH TSAI; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H.
臺大學術典藏	2021-03-04T02:35:57Z	Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma	Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; Tsai C.-L.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏	2021-03-04T02:35:57Z	Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma	Hu C.-Y.; YU-CHIEH TSAI; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; Lin W.-C.; Huang K.-H.
臺大學術典藏	2021-03-04T02:35:57Z	Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells	YU-CHIEH TSAI; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; Cheng A.-L.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏	2021-03-04T02:35:55Z	A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement	Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2021-03-04T02:35:55Z	Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population	Lin Y.-C.;Hour T.-C.;Yu-Chieh Tsai;Huang S.-P.;Wu W.-J.;Chen C.-H.;Pu Y.-S.;Chung S.-D.;Huang C.-Y.; Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI; Huang S.-P.; Wu W.-J.; Chen C.-H.; Pu Y.-S.; Chung S.-D.; Huang C.-Y.
臺大學術典藏	2021-03-04T02:35:54Z	Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma	Guo J.-C.;Yu-Chieh Tsai;Pu Y.-S.; Guo J.-C.; YU-CHIEH TSAI; Pu Y.-S.
臺大學術典藏	2021-02-02T08:29:56Z	Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions	Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; BOR-RU LIN; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y.

顯示項目 281-290 / 627 (共63頁)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
每頁顯示[10|25|50]項目